Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 at KeyCorp

Simulations Plus (NASDAQ:SLP) had its price objective increased by equities research analysts at KeyCorp from $35.00 to $37.00 in a report issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the technology company’s stock. KeyCorp’s price objective suggests a potential upside of 9.34% from the stock’s current price.

A number of other research analysts have also issued reports on the stock. BTIG Research decreased their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. Stephens assumed coverage on shares of Simulations Plus in a report on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Finally, StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $49.40.

Simulations Plus Price Performance

SLP stock traded up $0.34 during midday trading on Friday, hitting $33.84. The company’s stock had a trading volume of 68,365 shares, compared to its average volume of 352,778. The company’s fifty day moving average price is $29.77 and its 200 day moving average price is $32.93. Simulations Plus has a twelve month low of $24.00 and a twelve month high of $51.22. The stock has a market capitalization of $679.91 million, a P/E ratio of 84.45 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. During the same period in the previous year, the business earned $0.18 EPS. Simulations Plus’s revenue for the quarter was up 19.9% compared to the same quarter last year. Equities analysts expect that Simulations Plus will post 1.09 EPS for the current fiscal year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares in the company, valued at $109,336,467.84. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 19.40% of the company’s stock.

Institutional Investors Weigh In On Simulations Plus

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SLP. State Street Corp grew its position in shares of Simulations Plus by 4.7% in the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock valued at $14,367,000 after buying an additional 18,924 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after buying an additional 37,992 shares during the period. Tributary Capital Management LLC lifted its holdings in shares of Simulations Plus by 21.7% in the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock worth $11,047,000 after buying an additional 70,526 shares in the last quarter. Finally, Royce & Associates LP boosted its position in shares of Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after acquiring an additional 53,092 shares during the period. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.